Treatment exposure and discontinuation in the PALLAS trial: PALbociclib CoLlaborative Adjuvant Study of palbociclib with adjuvant endocrine therapy for HR+/HER2- early breast cancer (AFT-05)
- Citation:
- Meeting Instance:
- SABCS 2020
- Year:
- 2020
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- AFT
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3650
- Pharmas:
- Pfizer
- Grants:
- Corr. Author:
- Authors:
- Erica L. Mayer Christian Fesl Amylou Dueck Michael Gnant Angela DeMichele
- Networks:
- LAPS-MA036, LAPS-MN026
- Study
- AFT-05
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: